Paclitaxel oral solution plus Subcutaneous Pertuzumab/Trastuzumab
SYSKY-2025-397-01
Unknown small_molecule active
Quick answer
Paclitaxel oral solution plus Subcutaneous Pertuzumab/Trastuzumab for Breast Cancers is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Breast Cancers
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active